Search Results

62 results

  1. CORESTA Congress, Kunming, 2018, Plenary Session, IG 02

    Cigarette Variability Task Force study designs, statistical considerations, initial observations, and limitations

    MORTON M.J.(1); TAYYARAH R.(2); FLORA J.(1)
    (1) Altria Client Services LLC, Richmond, VA, U.S.A.; (2) ITG Brands, Greensboro, North Carolina, U.S.A. [Presented as a representative of the CVAR TF]
    The objective of the Cigarette Variability Task Force (CVAR TF) is to examine commercial cigarette variability through testing of select cigarette smoke and tobacco filler constituents plus select physical characteristics. To meet this objective, the CVAR ...
  2. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 25

    Misperception of e-cigarette harm growing among American adults, 2013-2015

    VERRON T.(1); GUO M.(1); VARIGNON B.(1); O'CONNELL G.(2); WALELE T.(2); CAHOURS X.(1)
    (1) SEITA - Imperial Brands plc, Paris, France; (2) Fontem Ventures B.V., Amsterdam, The Netherlands
    Electronic cigarettes (e cigarettes) have been characterised as significantly less harmful than smoked tobacco by an increasing number of public health authorities. However, the proportion of American adults who perceive e cigarettes to be equally or more ...
  3. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 52

    Biological test procedure for fresh generated cigarette smoke and e-cigarette aerosols under air-liquid interface (ALI) exposure in 24 and 96 multi-well plates

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    Cigarette smoke and e cigarette aerosol contain particulate matter/liquid droplets in the solid phase as well as volatile substances in the gas phase. Both fractions are of potential toxicological relevance and should be considered when assessing ...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 53

    Use of human derived cell lines to increase the biological relevance of cigarette condensate, non-tobacco materials and e-liquids testing

    WIECZOREK R.(1); TRELLES STICKEN E.(1); WALELE T.(2); CZEKALA L.(3); SIMMS L.(3)
    (1) Reemtsma Cigarettenfabriken GmbH, Imperial Brands plc, Hamburg, Germany; (2) Fontem Ventures, Amsterdam, The Netherlands; (3) Imperial Tobacco Limited, Bristol, U.K.
    The in vitro testing strategy of tobacco products is mainly based on the testing of extracts from cigarette smoke condensates. An accepted industry wide assay battery has been developed over recent years which delivers reliable results for the ...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 63 (also presented at TSRC 2018)

    Challenges and opportunities in cigar science

    SMITH J.H.(1); AUBUCHON S.M.(1); WAGNER K.A.(1); McKINNEY W.J.(1); GILLMAN I.G.(2); STEVENS R.(3)
    (1) Altria Client Services LLC, Richmond, VA, U.S.A.; (2) Enthalpy Analytical, Inc., Henrico, VA, U.S.A.; (3) ITG Brands LLC, Greensboro, NC, U.S.A.
    An independent Cigar Working Group has been formed by interested cigar stakeholders (e.g. manufacturers and testing laboratories). The goals of the Working Group are to explore opportunities for engagement with the Food and Drug Administration (FDA) on ...